Neoadjuvant therapy of pancreatic cancer: The emerging paradigm?

Keyphrases

• Pancreatic Cancer 100%
• Neoadjuvant Therapy 100%
• Neoadjuvant 100%
• Emergent Paradigm 100%
• Chemotherapy 33%
• Surgical Outcomes 33%
• Patient Demographics 33%
• Pathological Findings 33%
• Early Diagnosis 33%
• Neoadjuvant Chemotherapy 33%
• Surgical Complications 33%
• Combined Modality Therapy 33%
• Resectable Disease 33%
• Resectability 33%
• Surgical Candidate 33%
• Neoadjuvant Chemoradiotherapy (nCRT) 33%
• Preoperative Staging 33%
• Resistance to Chemotherapy 33%
• High Resistance 33%
• Complete Surgical Resection 33%
• Potentially Resectable 33%
• Borderline Resectable Disease 33%

Medicine and Dentistry

• Neoadjuvant Therapy 100%
• Pancreas Cancer 100%
• Diseases 66%
• Cancer 33%
• Recurrent Disease 33%
• Early Diagnosis 33%
• Patient Population 33%
• Chemoradiotherapy 33%
• Postoperative Complication 33%
• Neoadjuvant Chemotherapy 33%
• Surgery 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Chemotherapy 100%
• Pancreas Cancer 100%
• Diseases 66%
• Chemoradiation Therapy 33%
• Recurrent Disease 33%
• Postoperative Complication 33%